Maarten Schalekamp

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Chemicals & Drugs

Disorders

Anatomy

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Schalekamp Maarten Adh; Derkx Frans Hm; Deinum Jaap; Danser Ah Jan
Newly developed renin and prorenin assays and the clinical evaluation of renin inhibitors.
Schalekamp Maarten A D H
A local pre-receptor mechanism of hormone stimulus amplification: focus on angiotensin II in resistance blood vessels.
Schalekamp M A D H; Danser A H J
Angiotensin II production and distribution in the kidney: I. A kinetic model.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Maarten Schalekamp (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2008: Schalekamp Maarten Adh; Derkx Frans Hm; Deinum Jaap; Danser Ah Jan
Newly developed renin and prorenin assays and the clinical evaluation of renin inhibitors.
Journal of hypertension 2008;26(5):928-37.
2006: Schalekamp Maarten A D H
A local pre-receptor mechanism of hormone stimulus amplification: focus on angiotensin II in resistance blood vessels.
Journal of hypertension 2006;24(9):1787-96.
2006: Schalekamp M A D H; Danser A H J
Angiotensin II production and distribution in the kidney: I. A kinetic model.
Kidney international 2006;69(9):1543-52.
2006: Schalekamp M A D H; Danser A H J
Angiotensin II production and distribution in the kidney--II. Model-based analysis of experimental data.
Kidney international 2006;69(9):1553-7.
2006: Mattace-Raso Francesco U S; van der Cammen Tischa J M; Knetsch Anneke M; van den Meiracker Anton H; Schalekamp Maarten A D H; Hofman Albert; Witteman Jacqueline C M
Arterial stiffness as the candidate underlying mechanism for postural blood pressure changes and orthostatic hypotension in older adults: the Rotterdam Study.
Journal of hypertension 2006;24(2):339-44.
2006: Mattace-Raso Francesco U S; van der Cammen Tischa J M; Hofman Albert; van Popele Nicole M; Bos Michiel L; Schalekamp Maarten A D H; Asmar Roland; Reneman Robert S; Hoeks Arnold P G; Breteler Monique M B; Witteman Jacqueline C M
Arterial stiffness and risk of coronary heart disease and stroke: the Rotterdam Study.
Circulation 2006;113(5):657-63.
2005: Mattace-Raso Francesco U S; van der Cammen Tischa J M; van den Elzen Annette P M; Schalekamp Maarten A D H; Asmar Roland; Reneman Robert S; Hoeks Arnold P G; Hofman Albert; Witteman Jacqueline C M
Moderate alcohol consumption is associated with reduced arterial stiffness in older adults: the Rotterdam study.
The journals of gerontology. Series A, Biological sciences and medical sciences 2005;60(11):1479-83.
2005: van Kats Jorge P; Chai Wenxia; Duncker Dirk J; Schalekamp Maarten A D H; Danser A H Jan
Adrenal angiotensin: origin and site of generation.
American journal of hypertension 2005;18(8):1104-10.
2004: Mattace-Raso Francesco U S; van der Cammen Tischa J M; van Popele Nicole M; van der Kuip Deirdre A M; Schalekamp Maarten A D H; Hofman Albert; Breteler Monique M B; Witteman Jacqueline C M
Blood pressure components and cardiovascular events in older adults: the Rotterdam study.
Journal of the American Geriatrics Society 2004;52(9):1538-42.
2004: Mattace-Raso Francesco U S; van der Cammen Tischa J M; van der Meer Irene M; Schalekamp Maarten A D H; Asmar Roland; Hofman Albert; Witteman Jacqueline C M
C-reactive protein and arterial stiffness in older adults: the Rotterdam Study.
Atherosclerosis 2004;176(1):111-6.
2004: Mattace-Raso Francesco U S; van der Cammen Tischa J M; Sayed-Tabatabaei Fakhredin A; van Popele Nicole M; Asmar Roland; Schalekamp Maarten A D H; Hofman Albert; van Duijn Cornelia M; Witteman Jacqueline C M
Angiotensin-converting enzyme gene polymorphism and common carotid stiffness. The Rotterdam study.
Atherosclerosis 2004;174(1):121-6.
2002: Mattace-Raso Francesco; van Popele Nicole M; Schalekamp Maarten A D H; van der Cammen Tischa J M
Intima-media thickness of the common carotid arteries is related to coronary atherosclerosis and left ventricular hypertrophy in older adults.
Angiology 2002;53(5):569-74.
2002: Leertouwer Trude C; Derkx Frans H M; Pattynama Peter M T; Deinum Jaap; van Dijk Lukas C; Schalekamp Maarten A D H
Functional effects of renal artery stent placement on treated and contralateral kidneys.
Kidney international 2002;62(2):574-9.
2002: Saris Jasper J; van den Eijnden Mark M E D; Lamers Jos M J; Saxena Pramod R; Schalekamp Maarten A D H; Danser A H Jan
Prorenin-induced myocyte proliferation: no role for intracellular angiotensin II.
Hypertension 2002;39(2 Pt 2):573-7.
2002: Schuijt Martin P; de Vries René; Saxena Pramod R; Schalekamp Maarten A D H; Danser A H Jan
Vasoconstriction is determined by interstitial rather than circulating angiotensin II.
British journal of pharmacology 2002;135(1):275-83.
2001: van Kats J P; Schalekamp M A; Verdouw P D; Duncker D J; Danser A H
Intrarenal angiotensin II: interstitial and cellular levels and site of production.
Kidney international 2001;60(6):2311-7.
2001: van Jaarsveld B C; Krijnen P; Derkx F H; Deinum J; Woittiez A J; Postma C T; Schalekamp M A
Resistance to antihypertensive medication as predictor of renal artery stenosis: comparison of two drug regimens.
Journal of human hypertension 2001;15(10):669-76.
2001: van den Eijnden M M; Saris J J; de Bruin R J; de Wit E; Sluiter W; Reudelhuber T L; Schalekamp M A; Derkx F H; Danser A H
Prorenin accumulation and activation in human endothelial cells: importance of mannose 6-phosphate receptors.
Arteriosclerosis, thrombosis, and vascular biology 2001;21(6):911-6.
2001: de Lannoy L M; Schuijt M P; Saxena P R; Schalekamp M A; Danser A H
Angiotensin converting enzyme is the main contributor to angiotensin I-II conversion in the interstitium of the isolated perfused rat heart.
Journal of hypertension 2001;19(5):959-65.
2001: Saris J J; Derkx F H; De Bruin R J; Dekkers D H; Lamers J M; Saxena P R; Schalekamp M A; Jan Danser A H
High-affinity prorenin binding to cardiac man-6-P/IGF-II receptors precedes proteolytic activation to renin.
American journal of physiology. Heart and circulatory physiology 2001;280(4):H1706-15.
2001: van Kats J P; van Meegen J R; Verdouw P D; Duncker D J; Schalekamp M A; Danser A H
Subcellular localization of angiotensin II in kidney and adrenal.
Journal of hypertension 2001;19(3 Pt 2):583-9.
2001: Saris J J; Derkx F H; Lamers J M; Saxena P R; Schalekamp M A; Danser A H
Cardiomyocytes bind and activate native human prorenin : role of soluble mannose 6-phosphate receptors.
Hypertension 2001;37(2 Part 2):710-5.
2000: van Kats J P; Duncker D J; Haitsma D B; Schuijt M P; Niebuur R; Stubenitsky R; Boomsma F; Schalekamp M A; Verdouw P D; Danser A H
Angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade prevent cardiac remodeling in pigs after myocardial infarction: role of tissue angiotensin II.
Circulation 2000;102(13):1556-63.
2000: van Jaarsveld B C; Krijnen P; Pieterman H; Derkx F H; Deinum J; Postma C T; Dees A; Woittiez A J; Bartelink A K; Man in 't Veld A J; Schalekamp M A
The effect of balloon angioplasty on hypertension in atherosclerotic renal-artery stenosis. Dutch Renal Artery Stenosis Intervention Cooperative Study Group.
The New England journal of medicine 2000;342(14):1007-14.
2000: Saris J J; van Dijk M A; Kroon I; Schalekamp M A; Danser A H
Functional importance of angiotensin-converting enzyme-dependent in situ angiotensin II generation in the human forearm.
Hypertension 2000;35(3):764-8.
1999: Schuijt M P; van Kats J P; de Zeeuw S; Duncker D J; Verdouw P D; Schalekamp M A; Danser A H
Cardiac interstitial fluid levels of angiotensin I and II in the pig.
Journal of hypertension 1999;17(12 Pt 2):1885-91.
1999: Danser A H; Deinum J; Osterop A P; Admiraal P J; Schalekamp M A
Angiotensin I to angiotensin II conversion in the human forearm and leg. Effect of the angiotensin converting enzyme gene insertion/deletion polymorphism.
Journal of hypertension 1999;17(12 Pt 2):1867-72.
1999: van Jaarsveld B C; Pieterman H; van Dijk L C; van Seijen A J; Krijnen P; Derkx F H; Man in't Veld A J; Schalekamp M A
Inter-observer variability in the angiographic assessment of renal artery stenosis. DRASTIC study group. Dutch Renal Artery Stenosis Intervention Cooperative.
Journal of hypertension 1999;17(12 Pt 1):1731-6.
1999: MaassenVanDenBrink A; de Vries R; Saxena P R; Schalekamp M A; Danser A H
Vasoconstriction by in situ formed angiotensin II: role of ACE and chymase.
Cardiovascular research 1999;44(2):407-15.
1999: Deinum J; Rønn B; Mathiesen E; Derkx F H; Hop W C; Schalekamp M A
Increase in serum prorenin precedes onset of microalbuminuria in patients with insulin-dependent diabetes mellitus.
Diabetologia 1999;42(8):1006-10.
1999: Deinum J; Tarnow L; van Gool J M; de Bruin R A; Derkx F H; Schalekamp M A; Parving H H
Plasma renin and prorenin and renin gene variation in patients with insulin-dependent diabetes mellitus and nephropathy.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1999;14(8):1904-11.
1999: van Kesteren C A; Saris J J; Dekkers D H; Lamers J M; Saxena P R; Schalekamp M A; Danser A H
Cultured neonatal rat cardiac myocytes and fibroblasts do not synthesize renin or angiotensinogen: evidence for stretch-induced cardiomyocyte hypertrophy independent of angiotensin II.
Cardiovascular research 1999;43(1):148-56.
1999: Deinum J; Derkx F H; Schalekamp M A
Improved immunoradiometric assay for plasma renin.
Clinical chemistry 1999;45(6 Pt 1):847-54.
1999: Admiraal P J; van Kesteren C A; Danser A H; Derkx F H; Sluiter W; Schalekamp M A
Uptake and proteolytic activation of prorenin by cultured human endothelial cells.
Journal of hypertension 1999;17(5):621-9.
1998: Danser A H; Admiraal P J; Derkx F H; Schalekamp M A
Angiotensin I-to-II conversion in the human renal vascular bed.
Journal of hypertension 1998;16(12 Pt 2):2051-6.
1998: Broere A; Van Den Meiracker A H; Boomsma F; Derkx F H; Veld A J; Schalekamp M A
Human renal and systemic hemodynamic, natriuretic, and neurohumoral responses to different doses of L-NAME.
The American journal of physiology 1998;275(6 Pt 2):F870-7.
1998: Deinum J; Derkx F H; Schalekamp M A
Probing epitopes on human prorenin during its proteolytic and non-proteolytic activation.
Biochimica et biophysica acta 1998;1388(2):386-96.
1998: Krijnen P; van Jaarsveld B C; Steyerberg E W; Man in 't Veld A J; Schalekamp M A; Habbema J D
A clinical prediction rule for renal artery stenosis.
Annals of internal medicine 1998;129(9):705-11.
1998: Osterop A P; Kofflard M J; Sandkuijl L A; ten Cate F J; Krams R; Schalekamp M A; Danser A H
AT1 receptor A/C1166 polymorphism contributes to cardiac hypertrophy in subjects with hypertrophic cardiomyopathy.
Hypertension 1998;32(5):825-30.
1998: van Jaarsveld B; Krijnen P; Bartelink A; Dees A; Derkx F; Man in't Veld A; Schalekamp M
The Dutch Renal Artery Stenosis Intervention Cooperative (DRASTIC) Study: rationale, design and inclusion data.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1998;16(6):S21-7.
1998: van Kats J P; Danser A H; van Meegen J R; Sassen L M; Verdouw P D; Schalekamp M A
Angiotensin production by the heart: a quantitative study in pigs with the use of radiolabeled angiotensin infusions.
Circulation 1998;98(1):73-81.
1998: Danser A H; Derkx F H; Schalekamp M A; Hense H W; Riegger G A; Schunkert H
Determinants of interindividual variation of renin and prorenin concentrations: evidence for a sexual dimorphism of (pro)renin levels in humans.
Journal of hypertension 1998;16(6):853-62.
1998: de Lannoy L M; Danser A H; Bouhuizen A M; Saxena P R; Schalekamp M A
Localization and production of angiotensin II in the isolated perfused rat heart.
Hypertension 1998;31(5):1111-7.
1998: Zietse R; Derkx F H; Weimar W; Schalekamp M A
Angiotensin-converting enzyme inhibition does not correct early defects in renal and vascular permeability in diabetes mellitus.
Clinical science (London, England : 1979) 1998;94(2):165-73.
1997: van Kesteren C A; Danser A H; Derkx F H; Dekkers D H; Lamers J M; Saxena P R; Schalekamp M A
Mannose 6-phosphate receptor-mediated internalization and activation of prorenin by cardiac cells.
Hypertension 1997;30(6):1389-96.
1997: Danser A H; van Kats J P; Verdouw P D; Schalekamp M A
Evidence for the existence of a functional cardiac renin-angiotensin system in humans.
Circulation 1997;96(10):3795-6.
1997: Zietse R; Weimar W; Schalekamp M A
Atrial natriuretic peptide in diabetic nephropathy.
Kidney international. Supplement 1997;60():S33-41.
1997: van Kesteren C A; van Heugten H A; Lamers J M; Saxena P R; Schalekamp M A; Danser A H
Angiotensin II-mediated growth and antigrowth effects in cultured neonatal rat cardiac myocytes and fibroblasts.
Journal of molecular and cellular cardiology 1997;29(8):2147-57.
1997: Danser A H; van Kesteren C A; Bax W A; Tavenier M; Derkx F H; Saxena P R; Schalekamp M A
Prorenin, renin, angiotensinogen, and angiotensin-converting enzyme in normal and failing human hearts. Evidence for renin binding.
Circulation 1997;96(1):220-6.
1997: van Kats J P; de Lannoy L M; Jan Danser A H; van Meegen J R; Verdouw P D; Schalekamp M A
Angiotensin II type 1 (AT1) receptor-mediated accumulation of angiotensin II in tissues and its intracellular half-life in vivo.
Hypertension 1997;30(1 Pt 1):42-9.
1997: van Jaarsveld B C; Krijnen P; Derkx F H; Oei H Y; Postma C T; Schalekamp M A
The place of renal scintigraphy in the diagnosis of renal artery stenosis. Fifteen years of clinical experience.
Archives of internal medicine 1997;157(11):1226-34.
1997: de Lannoy L M; Danser A H; van Kats J P; Schoemaker R G; Saxena P R; Schalekamp M A
Renin-angiotensin system components in the interstitial fluid of the isolated perfused rat heart. Local production of angiotensin I.
Hypertension 1997;29(6):1240-51.
1997: Derkx F H; Schalekamp M A
More on renin.
Clinical chemistry 1997;43(4):694-7.
1997: Boomsma F; van Veldhuisen D J; de Kam P J; Man in't Veld A J; Mosterd A; Lie K I; Schalekamp M A
Plasma semicarbazide-sensitive amine oxidase is elevated in patients with congestive heart failure.
Cardiovascular research 1997;33(2):387-91.
1996: Derkx F H; van Jaarsveld B C; Krijnen P; Man in 't Veld A J; van den Meiracker A H; Schalekamp M A
Renal artery stenosis towards the year 2000.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1996;14(5):S167-72.
1996: Danser A H; Schalekamp M A
Is there an internal cardiac renin-angiotensin system?
Heart (British Cardiac Society) 1996;76(3 Suppl 3):28-32.
1996: Boomsma F; Bhaggoe U M; Man in 't Veld A J; Schalekamp M A
Comparison of N-terminal pro-atrial natriuretic peptide and atrial natriuretic peptide in human plasma as measured with commercially available radioimmunoassay kits.
Clinica chimica acta; international journal of clinical chemistry 1996;252(1):41-9.
1996: van den Dorpel M A; van den Meiracker A H; Lameris T W; Boomsma F; Levi M; Man in 't Veld A J; Weimar W; Schalekamp M A
Cyclosporin A impairs the nocturnal blood pressure fall in renal transplant recipients.
Hypertension 1996;28(2):304-7.
1996: Derkx F H; de Bruin R J; van Gool J M; van den Hoek M J; Beerendonk C C; Rosmalen F; Haima P; Schalekamp M A
Clinical validation of renin monoclonal antibody-based sandwich assays of renin and prorenin, and use of renin inhibitor to enhance prorenin immunoreactivity.
Clinical chemistry 1996;42(7):1051-63.
1996: van Kats J P; Sassen L M; Danser A H; Polak M P; Soei L K; Derkx F H; Schalekamp M A; Verdouw P D
Assessment of the role of the renin-angiotensin system in cardiac contractility utilizing the renin inhibitor remikiren.
British journal of pharmacology 1996;117(5):891-901.
1996: van Jaarsveld B C; Derkx F H; Krijnen P; Pieterman H; Man in't Veld A J; Woittiez A J; Dees A; Postma C T; Schalekamp M A
'Hypertension resistant to two-drug treatment' is a useful criterion to select patients for angiography: the 'Dutch Renal Artery Stenosis Intervention Cooperative' (DRASTIC) study.
Contributions to nephrology 1996;119():54-8.
1995: Bos W J; Zietse R; van den Meiracker A H; Schalekamp M A; Weimar W
Hemodynamic consequences of Cimino fistulas studied with finger pressure measurements during fistula compression.
Kidney international 1995;48(5):1641-5.
1995: Danser A H; Schalekamp M A; Bax W A; van den Brink A M; Saxena P R; Riegger G A; Schunkert H
Angiotensin-converting enzyme in the human heart. Effect of the deletion/insertion polymorphism.
Circulation 1995;92(6):1387-8.
1995: Bos W J; van den Meiracker A H; Wesseling K H; Schalekamp M A
Effect of regional and systemic changes in vasomotor tone on finger pressure amplification.
Hypertension 1995;26(2):315-20.
1995: Boomsma F; Bhaggoe U M; Man in 't Veld A J; Schalekamp M A
Sensitivity and specificity of a new ELISA method for determination of chromogranin A in the diagnosis of pheochromocytoma and neuroblastoma.
Clinica chimica acta; international journal of clinical chemistry 1995;239(1):57-63.
1995: Danser A H; Chowdury S; de Lannoy L M; van der Giessen W J; Saxena P R; Schalekamp M A
Conversion and degradation of [125I] labelled angiotensin I in isolated perfused porcine coronary and carotid arteries.
Cardiovascular research 1995;29(6):789-95.
1995: Boomsma F; Derkx F H; van den Meiracker A H; Man in 't Veld A J; Schalekamp M A
Plasma semicarbazide-sensitive amine oxidase activity is elevated in diabetes mellitus and correlates with glycosylated haemoglobin.
Clinical science (London, England : 1979) 1995;88(6):675-9.
1995: Zietse R; Derkx F H; Weimar W; Schalekamp M A
Effect of atrial natriuretic peptide on renal and vascular permeability in diabetes mellitus.
Journal of the American Society of Nephrology : JASN 1995;5(12):2057-66.
1995: van Dijk J; Boomsma F; Alberts G; Man in 't Veld A J; Schalekamp M A
Determination of semicarbazide-sensitive amine oxidase activity in human plasma by high-performance liquid chromatography with fluorimetric detection.
Journal of chromatography. B, Biomedical applications 1995;663(1):43-50.
1995: Zietse R; Blankestijn P J; Pos B; Balk A H; Derkx F H; Weimar W; Schalekamp M A
Optimising glomerular filtration rate and effective renal plasma flow measurements using a simple pharmacokinetic model.
Clinical nephrology 1995;43(1):29-34.
1995: Zietse R; Derkx F H; Schalekamp M A; Weimar W
Cyclosporin and the glomerular filtration barrier in minimal change disease and membranous glomerulopathy.
Contributions to nephrology 1995;114():6-18.
1995: Boomsma F; van den Meiracker A; Man in 't Veld A; Schalekamp M
Contrasting effects of peripheral decarboxylase inhibitors on plasma activity of aromatic-L-amino acid decarboxylase and semicarbazide-sensitive amine oxidase in Parkinson's disease.
Life sciences 1995;57(19):1753-9.
1994: Idema R N; van den Meiracker A H; Balk A H; Bos E; Schalekamp M A; Man in 't Veld A J
Abnormal diurnal variation of blood pressure, cardiac output, and vascular resistance in cardiac transplant recipients.
Circulation 1994;90(6):2797-803.
1994: Zietse R; van Ierland-van Leeuwen M L; Derkx F H; Ijzermans J N; Schalekamp M A; Weimar W
Glomerular barrier function following conversion from cyclosporine to azathioprine in renal transplant recipients.
American journal of kidney diseases : the official journal of the National Kidney Foundation 1994;24(6):927-31.
1994: Brink H S; Derkx F H; Boomsma F; Schalekamp M A
Effects of DDAVP on renal hemodynamics and renin secretion in subjects with essential hypertension.
Clinical nephrology 1994;42(2):95-101.
1994: Danser A H; van Kats J P; Admiraal P J; Derkx F H; Lamers J M; Verdouw P D; Saxena P R; Schalekamp M A
Cardiac renin and angiotensins. Uptake from plasma versus in situ synthesis.
Hypertension 1994;24(1):37-48.
1994: Derkx F H; Schalekamp M A
Renal artery stenosis and hypertension.
Lancet 1994;344(8917):237-9.
1994: van Eps R G; van den Meiracker A H; Boomsma F; Man in't Veld A J; Schalekamp M A
Diurnal variation of blood pressure in patients with catecholamine-producing tumors.
American journal of hypertension 1994;7(6):492-7.
1994: Idema R N; van den Meiracker A H; Balk A H; Bos E; Schalekamp M A; Man in't Veld A J
Decreased circadian blood pressure variation up to three years after heart transplantation.
The American journal of cardiology 1994;73(13):1006-9.
1994: Danser A H; Derkx F H; Admiraal P J; Deinum J; de Jong P T; Schalekamp M A
Angiotensin levels in the eye.
Investigative ophthalmology & visual science 1994;35(3):1008-18.
1994: van Jaarsveld B C; Pieterman H; Derkx F H; Schalekamp M A
[Hypertension caused by arterial fibromuscular dysplasia]
Nederlands tijdschrift voor geneeskunde 1994;138(5):225-8.
1994: van den Dorpel M A; Zietse R; Ijzermans J N; Schalekamp M A; Weimar W
Effect of isradipine on cyclosporin A-related hypertension.
Blood pressure. Supplement 1994;1():50-3.
1993: Boomsma F; Alberts G; van Eijk L; Man in 't Veld A J; Schalekamp M A
Optimal collection and storage conditions for catecholamine measurements in human plasma and urine.
Clinical chemistry 1993;39(12):2503-8.
1993: Idema R N; van den Meiracker A H; Man in 't Veld A J; Balk A H; Bos E; Schalekamp M A
Circadian hemodynamics in heart transplant recipients.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1993;11(5):S90-1.
1993: Derkx F H; de Bruin R J; van Gool J M; Rosmalen F M; van Hoek M J; Beerendonk C C; Schalekamp M A
A novel assay of plasma prorenin using a renin inhibitor.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1993;11(5):S240-1.
1993: Danser A H; Admiraal P J; Derkx F H; de Bruyn J H; Schalekamp M A
Changes in plasma renin and angiotensin run in parallel after nephrectomy.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1993;11(5):S238-9.
1993: Danser A H; Admiraal P J; Derkx F H; Lamers J M; Verdouw P D; Saxena P R; Schalekamp M A
Cardiac renin is kidney-derived.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1993;11(5):S224-5.
1993: Bhaggoe U M; Boomsma F; Admiraal P J; Man in 't Veld A J; Schalekamp M A
Is human atrial natriuretic peptide unstable at -80 degrees C?
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1993;11(5):S216-7.
1993: Derkx F H; van Jaarsveld B; Oei H Y; Pieterman H; van den Meiracker A H; Man in 't Veld A J; Schalekamp M A
Does captopril improve the diagnostic value of 99mTc-diethylenetriaminepentaacetic acid renography for renal artery stenosis?
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1993;11(5):S200-1.
1993: Statius van Eps R G; van den Meiracker A H; Boomsma F; Man in 't Veld A J; Schalekamp M A
Partial preservation of nocturnal fall in blood pressure in patients with catecholamine-producing tumours.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1993;11(5):S168-9.
1993: van den Meiracker A H; Tulen J H; Man in't Veld A J; Balk A H; van Steenis H G; Schalekamp M A
Blood pressure and heart rate variability in clinical models of cardiac denervation, sympathicolysis and sympathico- and parasympathicolysis.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1993;11(5):S152-3.
1993: Bhaggoe U M; Boomsma F; Admiraal P J; Man in 't Veld A J; Schalekamp M A
Stability of human plasma atrial natriuretic peptide during storage at -80 degrees C.
Clinica chimica acta; international journal of clinical chemistry 1993;223(1-2):179-84.
1993: Boomsma F; Alberts G; Bevers M M; Koning M M; Man in 't Veld A J; Schalekamp M A
Breakdown of 3,4-dihydroxybenzylamine and dopamine in plasma of various animal species by semicarbazide-sensitive amine oxidase.
Journal of chromatography 1993;621(1):82-8.
1993: Derkx F H; van den Meiracker A H; van Jaarsveld B C; Man in 't Veld A J; Pieterman H; Oei Y; Schalekamp M A
Captopril in the diagnostic work-up of hypertensive patients with suspected renal artery stenosis.
The Netherlands journal of medicine 1993;43 Suppl 1():S12-9.
1993: Blankestijn P J; Derkx F H; Birkenhäger J C; Lamberts S W; Mulder P; Verschoor L; Schalekamp M A; Weber R F
Glomerular hyperfiltration in insulin-dependent diabetes mellitus is correlated with enhanced growth hormone secretion.
The Journal of clinical endocrinology and metabolism 1993;77(2):498-502.
1993: Brink H S; Derkx F H; Boomsma F; Brommer E J; Schalekamp M A
1-Desamino-8-D-arginine vasopressin (DDAVP) in patients with congenital nephrogenic diabetes insipidus.
The Netherlands journal of medicine 1993;43(1-2):5-12.
1993: van den Meiracker A H; Admiraal P J; Derkx F H; Kleinbloesem C; Man in 't Veld A J; van Brummelen P; Mulder P; Schalekamp M A
Comparison of blood pressure and angiotensin responses to the renin inhibitor Ro 42-5892 and the angiotensin converting enzyme inhibitor enalapril in essential hypertension.
Journal of hypertension 1993;11(8):831-8.
1993: Boomsma F; van Woerkens L J; Man in 't Veld A J; Verdouw P D; Schalekamp M A
High activity of semicarbazide-sensitive amine oxidase (SSAO): an important source of errors in the determination of the concentration of dopamine in pig plasma.
Journal of cardiovascular pharmacology 1993;22(2):198-202.
1993: Admiraal P J; Danser A H; Jong M S; Pieterman H; Derkx F H; Schalekamp M A
Regional angiotensin II production in essential hypertension and renal artery stenosis.
Hypertension 1993;21(2):173-84.
1993: Schalekamp M A
Renin-angiotensin system components and endothelial proteins as markers of diabetic microvascular disease.
The Clinical investigator 1993;71(5 Suppl):S3-6.
1993: Vincent H H; Vos M C; Akçahuseyin E; Goessens W H; van Duyl W A; Schalekamp M A
Drug clearance by continuous haemodiafiltration. Analysis of sieving coefficients and mass transfer coefficients of diffusion.
Blood purification 1993;11(2):99-107.
1992: Alberts G; Boomsma F; Man in 't Veld A J; Schalekamp M A
Simultaneous determination of catecholamines and dobutamine in human plasma and urine by high-performance liquid chromatography with fluorimetric detection.
Journal of chromatography 1992;583(2):236-40.
1992: Schalekamp M A; Derkx F H; van den Meiracker A H
Renin inhibitors, angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists: relationships between blood pressure responses and effects on the renin-angiotensin system.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1992;10(7):S157-64.
1992: Derkx F H; Deinum J; Lipovski M; Verhaar M; Fischli W; Schalekamp M A
Nonproteolytic "activation" of prorenin by active site-directed renin inhibitors as demonstrated by renin-specific monoclonal antibody.
The Journal of biological chemistry 1992;267(32):22837-42.
1992: Danser A H; Koning M M; Admiraal P J; Sassen L M; Derkx F H; Verdouw P D; Schalekamp M A
Production of angiotensins I and II at tissue sites in intact pigs.
The American journal of physiology 1992;263(2 Pt 2):H429-37.
1992: Danser A H; Koning M M; Admiraal P J; Derkx F H; Verdouw P D; Schalekamp M A
Metabolism of angiotensin I by different tissues in the intact animal.
The American journal of physiology 1992;263(2 Pt 2):H418-28.
1992: van den Meiracker A H; Man in 't Veld A J; Admiraal P J; Ritsema van Eck H J; Boomsma F; Derkx F H; Schalekamp M A
Partial escape of angiotensin converting enzyme (ACE) inhibition during prolonged ACE inhibitor treatment: does it exist and does it affect the antihypertensive response?
Journal of hypertension 1992;10(8):803-12.
1992: Zietse R; Wenting G J; Kramer P; Schalekamp M A; Weimar W
Effects of cyclosporin A on glomerular barrier function in the nephrotic syndrome.
Clinical science (London, England : 1979) 1992;82(6):641-50.
1992: Boomsma F; Alberts G; van der Hoorn F A; Man in 't Veld A J; Schalekamp M A
Simultaneous determination of free catecholamines and epinine and estimation of total epinine and dopamine in plasma and urine by high-performance liquid chromatography with fluorimetric detection.
Journal of chromatography 1992;574(1):109-17.
1992: Vincent H H; Vos M C; Akcahuseyin E; van Duyl W A; Schalekamp M A
Blood flow, ultrafiltration and solute transport rate in continuous arteriovenous haemodiafiltration: the AN-69 flat-plate haemofilter.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1992;7(1):29-34.
1991: Boomsma F; in 't Veld A J; Schalekamp M A
Specific binding of catecholamines to plasma proteins: fact or artefact?
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1991;9(6):S92-3.
1991: Blankestijn P J; Tulen J; Man in 't Veld A J; Boomsma F; Schalekamp M A
'Stress' levels of adrenaline mediate a protracted amplification of the blood pressure response to sympathetic stimulation in man.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1991;9(6):S76-7.
1991: Danser A H; Sassen L M; Admiraal P J; Derkx F H; Verdouw P D; Schalekamp M A
Regional production of angiotensins I and II: contribution of vascular kidney-derived renin.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1991;9(6):S234-5.
1991: Admiraal P J; Danser A H; Derkx F H; Schalekamp M A
Angiotensin II production in different vascular beds in hypertensive subjects.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1991;9(6):S208-9.
1991: Florijn K W; Derkx F H; Visser W; Hofman H J; Rosmalen F M; Wallenburg H C; Schalekamp M A
Elevated plasma levels of endothelin in pre-eclampsia.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1991;9(6):S166-7.
1991: Schalekamp M A
Second Björn Folkow Award Lecture. The renin-angiotensin system: new surprises ahead.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1991;9(6):S10-7.
1991: Mannesse C K; Blankestijn P J; Man in 't Veld A J; Schalekamp M A
Renal failure and cholesterol crystal embolization: a report of 4 surviving cases and a review of the literature.
Clinical nephrology 1991;36(5):240-5.
1991: Derkx F H; van den Meiracker A H; Fischli W; Admiraal P J; Man in't Veld A J; van Brummelen P; Schalekamp M A
Nonparallel effects of renin inhibitor treatment on plasma renin activity and angiotensins I and II in hypertensive subjects. An assay-related artifact.
American journal of hypertension 1991;4(7 Pt 1):602-9.
1991: van der Hoorn F A; Boomsma F; Man in 't Veld A J; Schalekamp M A
Improved measurement of urinary catecholamines by liquid-liquid extraction, derivatization and high-performance liquid chromatography with fluorimetric detection.
Journal of chromatography 1991;563(2):348-55.
1991: Vincent H H; Akcahuseyin E; Vos M C; van Duyl W A; Schalekamp M A
Continuous arteriovenous hemodiafiltration: filter design and blood flow rate.
Contributions to nephrology 1991;93():196-8.
1991: Florijn K W; Derkx F H; Visser W; Hofman J A; Rosmalen F M; Wallenburg H C; Schalekamp M A
Plasma immunoreactive endothelin-1 in pregnant women with and without pre-eclampsia.
Journal of cardiovascular pharmacology 1991;17 Suppl 7():S446-8.
1990: Admiraal P J; Derkx F H; Danser A H; Pieterman H; Schalekamp M A
Intrarenal de novo production of angiotensin I in subjects with renal artery stenosis.
Hypertension 1990;16(5):555-63.
1990: Blankestijn P J; Derkx F H; Van Geelen J A; De Jong F H; Schalekamp M A
Increase in plasma prorenin during the menstrual cycle of a bilaterally nephrectomized woman.
British journal of obstetrics and gynaecology 1990;97(11):1038-42.
1990: Franken A A; Derkx F H; Man in't Veld A J; Hop W C; van Rens G H; Peperkamp E; de Jong P T; Schalekamp M A
High plasma prorenin in diabetes mellitus and its correlation with some complications.
The Journal of clinical endocrinology and metabolism 1990;71(4):1008-15.
1990: van den Meiracker A H; Admiraal P J; Man in 't Veld A J; Derkx F H; Ritsema van Eck H J; Mulder P; van Brummelen P; Schalekamp M A
Prolonged blood pressure reduction by orally active renin inhibitor RO 42-5892 in essential hypertension.
BMJ (Clinical research ed.) 1990;301(6745):205-10.
1990: Brouwer R M; Wenting G J; Schalekamp M A
Acute effects and mechanism of action of ketanserin in patients with primary Raynaud's phenomenon.
Journal of cardiovascular pharmacology 1990;15(6):868-76.
1990: van den Meiracker A H; Man in 't Veld A J; Boomsma F; Blankestijn P J; Schalekamp M A
Epinephrine-induced enhancement of sympathetic activity in humans: inhibition by nonselective as well as beta 1-selective beta-adrenoceptor blockade.
Journal of cardiovascular pharmacology 1990;15(4):610-7.
1990: Deinum J; Derkx F H; Danser A H; Schalekamp M A
Identification and quantification of renin and prorenin in the bovine eye.
Endocrinology 1990;126(3):1673-82.
1990: Akcahuseyin E; Vincent H H; van Ittersum F J; van Duyl W A; Schalekamp M A
A mathematical model of continuous arterio-venous hemodiafiltration (CAVHD).
Computer methods and programs in biomedicine 1990;31(3-4):215-24.
1990: Admiraal P J; Derkx F H; Danser A H; Pieterman H; Schalekamp M A
Metabolism and production of angiotensin I in different vascular beds in subjects with hypertension.
Hypertension 1990;15(1):44-55.
1990: Vincent H H; van Ittersum F J; Akcahuseyin E; Vos M C; van Duyl W A; Schalekamp M A
Solute transport in continuous arteriovenous hemodiafiltration: a new mathematical model applied to clinical data.
Blood purification 1990;8(3):149-59.
1990: Vincent H H; Akçahuseyin E; Vos M C; van Ittersum F J; van Duyl W A; Schalekamp M A
Determinants of blood flow and ultrafiltration in continuous arteriovenous haemodiafiltration: theoretical predictions and laboratory and clinical observations.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1990;5(12):1031-7.
1989: Admiraal P J; Derkx F H; Danser A H; Schalekamp M A
In vivo production of plasma angiotensin I: is plasma renin sufficient?
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1989;7(6):S222-3.
1989: Deinum J; Derkx F H; Danser A H; Schalekamp M A
Renin in the bovine eye.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1989;7(6):S216-7.
1989: Idema R N; van den Meiracker A H; Imholz B P; Man in 't Veld A J; Settels J J; Ritsema van Eck H J; Schalekamp M A
Comparison of Finapres non-invasive beat-to-beat finger blood pressure with intrabrachial artery pressure during and after bicycle ergometry.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1989;7(6):S58-9.
1989: van den Meiracker A H; Man in 't Veld A J; Ritsema van Eck H J; Schalekamp M A
Comparison of the acute and chronic antihypertensive effect of two once-daily doses of spirapril by invasive twenty-four-hour ambulatory blood pressure monitoring.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1989;7(6):S302-3.
1989: van den Meiracker A H; Man in't Veld A J; Boomsma F; Fischberg D J; Molinoff P B; Schalekamp M A
Hemodynamic and beta-adrenergic receptor adaptations during long-term beta-adrenoceptor blockade. Studies with acebutolol, atenolol, pindolol, and propranolol in hypertensive patients.
Circulation 1989;80(4):903-14.
1989: Boomsma F; Ausema L; Hakvoort-Cammel F G; Oosterom R; Man in't Veld A J; Krenning E P; Hahlen K; Schalekamp M A
Combined measurements of plasma aromatic L-amino acid decarboxylase and DOPA as tumour markers in diagnosis and follow-up of neuroblastoma.
European journal of cancer & clinical oncology 1989;25(7):1045-52.
1989: Boomsma F; Meerwaldt J D; Man in 't Veld A J; Hovestadt A; Schalekamp M A
Induction of aromatic-L-amino acid decarboxylase by decarboxylase inhibitors in idiopathic parkinsonism.
Annals of neurology 1989;25(6):624-8.
1989: Janssen J A; Blankestijn P J; Docter R; Blijenberg B G; Splinter T A; van Toor H; Schalekamp M A; Lamberts S W; Krenning E P
Effects of immunoscintigraphy with monoclonal antibodies in assays of hormones and tumour markers.
BMJ (Clinical research ed.) 1989;298(6686):1511-3.
1989: Boomsma F; Meerwaldt J D; Man in't Veld A J; Hovestadt A; Schalekamp M A
Treatment of idiopathic parkinsonism with L-dopa in the absence and presence of decarboxylase inhibitors: effects on plasma levels of L-dopa, dopa decarboxylase, catecholamines and 3-O-methyl-dopa.
Journal of neurology 1989;236(4):223-30.
1989: Zietse R; Wenting G J; Kramer P; Mulder P; Schalekamp M A; Weimar W
Contrasting response to cyclosporin in refractory nephrotic syndrome.
Clinical nephrology 1989;31(1):22-5.
1989: van der Hoorn F A; Boomsma F; Man in 't Veld A J; Schalekamp M A
Determination of catecholamines in human plasma by high-performance liquid chromatography: comparison between a new method with fluorescence detection and an established method with electrochemical detection.
Journal of chromatography 1989;487(1):17-28.
1989: Danser A H; van den Dorpel M A; Deinum J; Derkx F H; Franken A A; Peperkamp E; de Jong P T; Schalekamp M A
Renin, prorenin, and immunoreactive renin in vitreous fluid from eyes with and without diabetic retinopathy.
The Journal of clinical endocrinology and metabolism 1989;68(1):160-7.
1989: Schalekamp M A; Admiraal P J; Derkx F H
Estimation of regional metabolism and production of angiotensins in hypertensive subjects.
British journal of clinical pharmacology 1989;28 Suppl 2():105S-112S; discussion 112S-113S.
1988: Man in 't Veld A J; Boomsma F; van den Meiracker A H; Julien C; Lenders J; Schalekamp M A
d,l-threo-3,4-dihydroxyphenylserine restores sympathetic control and cures orthostatic hypotension in dopamine beta-hydroxylase deficiency.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1988;6(4):S547-9.
1988: Franken A A; Derkx F H; Schalekamp M A; Man in t'Veld A J; Hop W C; van Rens E H; de Jong P T
Association of high plasma prorenin with diabetic retinopathy.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1988;6(4):S461-3.
1988: Brouwer R M; Wenting G J; Zijlstra F; Balk A H; Mochtar B; Derkx F H; de Bruin R J; Weimar W; Schalekamp M A
Atrial wall stress rather than pressure per se might be responsible for the increased secretion of atrial natriuretic factor after heart transplantation.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1988;6(4):S330-2.
1988: van den Meiracker A H; Man in't Veld A J; Boomsma F; Blankestijn P J; Schalekamp M A
Adrenaline-induced amplification of sympathetic activity during rest and stress: inhibition by non-selective and beta 1-selective beta-adrenoceptor blockade.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1988;6(4):S558-61.
1988: Boomsma F; van der Hoorn F A; Man in 't Veld A J; Schalekamp M A
Determination of 3,4-dihydroxyphenylalanine (DOPA) in plasma and cerebrospinal fluid by high performance liquid chromatography with electrochemical detection.
Clinica chimica acta; international journal of clinical chemistry 1988;178(1):59-69.
1988: Zietse R; Schalekamp M A
Effect of synthetic human atrial natriuretic peptide (102-126) in nephrotic syndrome.
Kidney international 1988;34(5):717-24.
1988: van den Meiracker A H; Man in 't Veld A J; van Eck H J; Boomsma F; Schalekamp M A
Hemodynamic and hormonal adaptations to beta-adrenoceptor blockade. A 24-hour study of acebutolol, atenolol, pindolol, and propranolol in hypertensive patients.
Circulation 1988;78(4):957-68.
1988: Man in 't Veld A; Boomsma F; Lenders J; vd Meiracker A; Julien C; Tulen J; Moleman P; Thien T; Lamberts S; Schalekamp M
Patients with congenital dopamine beta-hydroxylase deficiency. A lesson in catecholamine physiology.
American journal of hypertension 1988;1(3 Pt 1):231-8.
1988: Zietse R; Wenting G J; Kramer P; Schalekamp M A; Weimar W
Fractional excretion of protein: a marker of the efficacy of cyclosporine A treatment in nephrotic syndrome.
Transplantation proceedings 1988;20(3 Suppl 4):280-4.
1988: Vincent H H; Wenting G J; Versluis D J; Weimar W; Schalekamp M A
Impaired fractional excretion of lithium: an early marker of cyclosporine-induced changes in renal hemodynamics.
Transplantation proceedings 1988;20(3 Suppl 3):681-5.
1988: Boomsma F; van der Hoorn F A; Man in 't Veld A J; Schalekamp M A
Determination of D,L-threo-3,4-dihydroxyphenylserine and of the D- and L-enantiomers in human plasma and urine.
Journal of chromatography 1988;427(2):219-27.
1988: van den Meiracker A H; Man in 't Veld A J; Fischberg D J; Molinoff P B; van Eck H J; Boomsma F; Derkx F H; Schalekamp M A
Acute and long-term effects of acebutolol on systemic and renal hemodynamics, body fluid volumes, catecholamines, active renin, aldosterone, and lymphocyte beta-adrenoceptor density.
Journal of cardiovascular pharmacology 1988;11(4):413-23.
1988: van den Meiracker A H; Man in 't Veld A J; van Eck H J; Wenting G J; Schalekamp M A
Determinants of short-term blood pressure variability. Effects of bed rest and sensory deprivation in essential hypertension.
American journal of hypertension 1988;1(1):22-6.
1988: Man in't Veld A J; Van den Meiracker A H; Schalekamp M A
Do beta-blockers really increase peripheral vascular resistance? Review of the literature and new observations under basal conditions.
American journal of hypertension 1988;1(1):91-6.
1988: van Geelen J A; Vincent H H; Schalekamp M A
Continuous arteriovenous haemofiltration and haemodiafiltration in acute renal failure.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1988;3(2):181-6.
1988: Danser A H; van den Dorpel M A; Deinum J; Derkx F H; Peperkamp E; de Jong P T; Schalekamp M A
Prorenin in vitreous and subretinal fluid of the human eye.
Clinical and experimental hypertension. Part A, Theory and practice 1988;10(6):1297-9.
1988: Derkx F H; Schalekamp M A
Human prorenin: pathophysiology and clinical implications.
Clinical and experimental hypertension. Part A, Theory and practice 1988;10(6):1213-25.
1988: Man in 't Veld A J; van den Meiracker A H; Schalekamp M A
Age dependency of blood pressure response to antihypertensive treatment: some methodological considerations and observations on five beta-adrenoceptor antagonists under different experimental conditions.
Journal of cardiovascular pharmacology 1988;12 Suppl 8():S93-9.
1987: Man in 't Veld A J; Boomsma F; van den Meiracker A H; Schalekamp M A
Effect of unnatural noradrenaline precursor on sympathetic control and orthostatic hypotension in dopamine-beta-hydroxylase deficiency.
Lancet 1987;2(8569):1172-5.
1987: Vincent H H; Wenting G J; Schalekamp M A; Jeekel J; Weimar W
Impaired fractional excretion of lithium: a very early marker of cyclosporine nephrotoxicity.
Transplantation proceedings 1987;19(5):4147-8.
1987: van den Meiracker A H; Man in 't Veld A J; van Eck H J; Boomsma F; Derkx F H; Mulder P; Schalekamp M A
The clinical pharmacology of bopindolol, a new long-acting beta-adrenoceptor antagonist, in hypertension.
Clinical pharmacology and therapeutics 1987;42(4):411-9.
1987: Versluis D J; Wenting G J; Derkx F H; Schalekamp M A; Jeekel J; Weimar W
Who should be converted from cyclosporine to conventional immunosuppression in kidney transplantation, and why.
Transplantation 1987;44(3):387-9.
1987: van Geelen J A; Woittiez A J; Schalekamp M A
Bicarbonate versus acetate hemodialysis in ventilated patients.
Clinical nephrology 1987;28(3):130-3.
1987: Wenting G J; Derkx F H; Tan-Tjiong L H; van Seyen A J; Man in't Veld A J; Schalekamp M A
Risks of angiotensin converting enzyme inhibition in renal artery stenosis.
Kidney international. Supplement 1987;20():S180-3.
1987: Wenting G J; Blankestijn P J; Poldermans D; van Geelen J; Derkx F H; Man in't Veld A J; Schalekamp M A
Blood pressure response of nephrectomized subjects and patients with essential hypertension to ramipril: indirect evidence that inhibition of tissue angiotensin converting enzyme is important.
The American journal of cardiology 1987;59(10):92D-97D.
1987: Wenting G J; vd Meiracker A H; Simoons M L; Bos E; Ritsema v Eck H J; Man in 't Veld A J; Weimar W; Schalekamp M A
Circadian variation of heart rate but not of blood pressure after heart transplantation.
Transplantation proceedings 1987;19(1 Pt 3):2554-5.
1987: Weimar W; Versluis D J; Wenting G J; Derkx F H; Schalekamp M A; Jeekel J
Prolonged cyclosporine therapy to induce solid engraftment after renal transplantation.
Transplantation proceedings 1987;19(1 Pt 3):1998-9.
1987: Vincent H H; Wenting G J; Jeekel J; Schalekamp M A; Weimar W
Dihydroergotoxine (hydergine) to prevent cyclosporine nephrotoxicity in kidney transplant recipients.
Transplantation proceedings 1987;19(1 Pt 2):1737-8.
1987: van den Meiracker A H; Man in't Veld A J; Schalekamp M A
Comparison of the onset of the antihypertensive action of pindolol and propranolol. A 24 h haemodynamic study.
British journal of clinical pharmacology 1987;24 Suppl 1():39S-44S.
1987: Derkx F H; Tan-Tjiong H L; van Seyen A J; Wenting G J; Man in 't Veld A J; Schalekamp M A
Renal vein immunoreactive renin in patients with renal artery stenosis and essential hypertension.
Clinical and experimental hypertension. Part A, Theory and practice 1987;9(8-9):1341-52.
1987: Wenting G J; Brouwer R M; vd Meiracker A J; Man in't Veld A J; Schalekamp M A
Mechanism of action of ketanserin in hypertension and vasospastic disease.
Acta cardiologica 1987;42(5):339-54.
1987: Brouwer R M; Wenting G J; Man in't Veld A J; Schalekamp M A
Role of alpha-adrenergic blockade in the cardiovascular actions of ketanserin: studies in patients with essential hypertension, autonomic insufficiency, and Raynaud's phenomenon.
Journal of cardiovascular pharmacology 1987;10 Suppl 3():S26-31.
1986: van den Meiracker A H; Man in 't Veld A J; Ritsema van Eck H J; Schalekamp M A
Systemic and renal vasodilation after beta-adrenoceptor blockade with pindolol: a hemodynamic study on the onset and maintenance of its antihypertensive effect.
American heart journal 1986;112(2):368-74.
1986: Schalekamp M A; Woittiez A J; Wenting G J; van den Meiracker A H; Man in 't Veld A J
Ketanserin: haemodynamic effects and mechanism of action.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1986;4(1):S7-12.
1986: Woittiez A J; Wenting G J; van den Meiracker A H; Ritsema van Eck H J; Man in't Veld A J; Zantvoort F A; Schalekamp M A
Chronic effect of ketanserin in mild to moderate essential hypertension.
Hypertension 1986;8(2):167-73.
1985: Vincent H H; Man in 't Veld A J; Boomsma F; Derkx F; Schalekamp M A
Compound ICI 118,551, a beta 2-adrenoceptor antagonist, lowers blood pressure.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1985;3(3):S247-9.
1985: Wenting G J; Man in 't Veld A J; Boomsma F; Schalekamp M A
Cyclic blood pressure changes in a patient with a phaeochromocytoma: role of a central oscillator?
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1985;3(3):S347-9.
1985: Derkx F H; Tan-Tjiong L H; Wenting G J; Man in 't Veld A; Schalekamp M A
Use of captopril in the diagnostic work-up of renovascular hypertension.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1985;3(3):S287-9.
1985: Woittiez A J; Wenting G J; Man in't Veld A J; Boomsma F; Schalekamp M A
Ketanserin: a possible tool for studying the role of serotonin in hypertension.
Journal of cardiovascular pharmacology 1985;7 Suppl 7():S130-6.
1984: Wenting G J; Tan-Tjiong H L; Derkx F H; de Bruyn J H; Man in't Veld A J; Schalekamp M A
Splint renal function after captopril in unilateral renal artery stenosis.
British medical journal (Clinical research ed.) 1984;288(6421):886-90.
1984: Wenting G J; Woittiez A J; Man in't Veld A J; Schalekamp M A
5-HT, alpha-adrenoceptors, and blood pressure. Effects of ketanserin in essential hypertension and autonomic insufficiency.
Hypertension 1984;6(1):100-9.
1983: Derkx F H; Tan-Tjiong L; Wenting G J; Boomsma F; Man in 't Veld A J; Schalekamp M A
Asynchronous changes in prorenin and renin secretion after captopril in patients with renal artery stenosis.
Hypertension 1983;5(2):244-56.
1983: Wenting G J; Man in't veld A J; Woittiez A J; Boomsma F; Laird-Meeter K; Simoons M L; Hugenholtz P G; Schalekamp M A
Effects of captopril in acute and chronic heart failure. Correlations with plasma levels of noradrenaline, renin, and aldosterone.
British heart journal 1983;49(1):65-76.
1982: Wenting G J; de Bruyn J H; Man in't Veld A J; Woittiez A J; Derkx F H; Schalekamp M A
Hemodynamic effects of captopril in essential hypertension, renovascular hypertension and cardiac failure: correlations with short- and long-term effects on plasma renin.
The American journal of cardiology 1982;49(6):1453-9.
1982: Wenting G J; Man in 't Veld A J; Woittiez A J; Boomsma F; Schalekamp M A
Treatment of hypertension with ketanserin, a new selective 5-HT2 receptor antagonist.
British medical journal (Clinical research ed.) 1982;284(6315):537-9.
1981: de Bruyn J H; Man in't Veld A J; Wenting G J; Derkx F H; Schalekamp M A
Haemodynamic profile of captopril treatment in various forms of hypertension.
European journal of clinical pharmacology 1981;20(3):163-8.
1980: Derkx F H; Bouma B N; Tan-Tjiong H L; Man in 't Veld A J; de Bruyn J H; Wenting G J; Schalekamp M A
Role of plasma kallikrein in the proteolytic activation of the renin-angiotensin system.
Clinical and experimental hypertension 1980;2(3-4):575-92.
1980: Derkx F H; Bouma B N; Tan Tjiong H L; Man in 't Veld A J; de Bruyn J H; Wenting G J; Schalekamp M A
The plasma kallikrein-renin connection.
Archives internationales de pharmacodynamie et de thérapie 1980;Suppl():165-77.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Maarten Schalekamp

Research Profile (preview)

Chemicals & Drugs

Disorders

Anatomy

Physiology

Living Beings

Concepts & Ideas

Phenomena

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Maarten Schalekamp (preview)

All Publications